Literature DB >> 508557

Probenecid: an unexplained effect on cephalosporin pharmacology.

P G Welling, S Dean, A Selen, M J Kendall, R Wise.   

Abstract

1 The influence of probenecid on serum levels and urinary excretion of orally administered cephradine and cefaclor has been investigated. 2 Probenecid caused serum levels of both antibiotics to be increased and also prolonged. Urinary excretion of antibiotic activity was slightly but not significantly decreased by probenecid during the initial 6 h postdosing. It was significantly increased in 6-12 h urine, but only a small percentage of the doses were excreted during that period. 3 The increased serum levels of antibiotic were greater than could be accounted for by reduced elimination rate alone. Possible mechanisms to account for increased circulating levels of antibiotic in the presence of probenecid are discussed in the light of previous observations on probenecid induced changes in tissue distribution of beta-lactam antibiotics.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 508557      PMCID: PMC1429805          DOI: 10.1111/j.1365-2125.1979.tb01032.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  16 in total

1.  Experimental changes in liver function induced by probenecid.

Authors:  A E GOETZEE; T G RICHARDS; V R TINDALL
Journal:  Clin Sci       Date:  1960-02       Impact factor: 6.124

2.  Effect of probenecid on the apparent volume of distribution and elimination of cloxacillin.

Authors:  E H Nauta; H Mattie; W R Goslings
Journal:  Antimicrob Agents Chemother       Date:  1974-09       Impact factor: 5.191

3.  Effect of probenecid on the blood levels and urinary excretion of cefamandole.

Authors:  R S Griffith; H R Black; G L Brier; J D Wolny
Journal:  Antimicrob Agents Chemother       Date:  1977-05       Impact factor: 5.191

4.  Stability and blood level determinations of cefaclor, a new oral cephalosporin antibiotic.

Authors:  M A Foglesong; J W Lamb; J V Dietz
Journal:  Antimicrob Agents Chemother       Date:  1978-01       Impact factor: 5.191

Review 5.  Protein binding of antimicrobials: clinical pharmacokinetic and therapeutic implications.

Authors:  W A Craig; P G Welling
Journal:  Clin Pharmacokinet       Date:  1977 Jul-Aug       Impact factor: 6.447

6.  Standardization of a preparative ultracentrifuge method for quantitative determination or protein binding of seven antibiotics.

Authors:  L R Peterson; W H Hall; H H Zinneman; D N Gerding
Journal:  J Infect Dis       Date:  1977-12       Impact factor: 5.226

Review 7.  Cephradine--a summary of preclinical studies and clinical pharmacology.

Authors:  E S Neiss
Journal:  J Ir Med Assoc       Date:  1973-03-24

8.  A human pharmacology study of cefaclor.

Authors:  A Glynne; R A Goulbourn; R Ryden
Journal:  J Antimicrob Chemother       Date:  1978-07       Impact factor: 5.790

9.  Effect of probenecid on serum cefoxitin concentrations.

Authors:  A J Bint; D S Reeves; H A Holt
Journal:  J Antimicrob Chemother       Date:  1977-11       Impact factor: 5.790

10.  Probenecid and the antibacterial activity of cephradine in vivo.

Authors:  M W Kunst; H Mattie
Journal:  J Infect Dis       Date:  1978-06       Impact factor: 5.226

View more
  14 in total

Review 1.  Renal organic anion transporters (SLC22 family): expression, regulation, roles in toxicity, and impact on injury and disease.

Authors:  Li Wang; Douglas H Sweet
Journal:  AAPS J       Date:  2012-10-09       Impact factor: 4.009

2.  Effect of probenecid on the pharmacokinetics of moxalactam.

Authors:  K A DeSante; K S Israel; G L Brier; J D Wolny; B L Hatcher
Journal:  Antimicrob Agents Chemother       Date:  1982-01       Impact factor: 5.191

3.  Pharmacokinetics of cephradine given intravenously with and without probenecid.

Authors:  D H Roberts; M J Kendall; D B Jack; P G Welling
Journal:  Br J Clin Pharmacol       Date:  1981-06       Impact factor: 4.335

Review 4.  Side effects of cephalosporins.

Authors:  S R Norrby
Journal:  Drugs       Date:  1987       Impact factor: 9.546

5.  The effects of frusemide and probenecid on the pharmacokinetics of phenprocoumon.

Authors:  H Mönig; M Böhm; E E Ohnhaus; W Kirch
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

Review 6.  Cephalosporin-probenecid drug interactions.

Authors:  G R Brown
Journal:  Clin Pharmacokinet       Date:  1993-04       Impact factor: 6.447

7.  The effect of probenecid on the pharmacokinetics and distribution of cefoxitin in healthy volunteers.

Authors:  D S Reeves; D W Bullock; M J Bywater; H A Holt; L O White; D P Thornhill
Journal:  Br J Clin Pharmacol       Date:  1981-04       Impact factor: 4.335

8.  Reduction of metformin renal tubular secretion by cimetidine in man.

Authors:  A Somogyi; C Stockley; J Keal; P Rolan; F Bochner
Journal:  Br J Clin Pharmacol       Date:  1987-05       Impact factor: 4.335

9.  Effects of urinary pH on renal interactions between probenecid and cefsulodin in rabbits.

Authors:  F Dromer; A Contrepois; N Brion; C Klein; C Carbon
Journal:  Antimicrob Agents Chemother       Date:  1985-04       Impact factor: 5.191

Review 10.  Clinical pharmacokinetics of probenecid.

Authors:  R F Cunningham; Z H Israili; P G Dayton
Journal:  Clin Pharmacokinet       Date:  1981 Mar-Apr       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.